Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microbiome of Depression &Amp; Treatment Response to Citalopram: A Feasibility Study

NCT02330068 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02330068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02330068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microbiome of Depression &Amp; Treatment Response to Citalopram: A Feasibility Study
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
December 31, 2014
Completion date
December 31, 2017
Enrollment
34 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, bipolar i and bipolar ii